21. Substituted piperidines having protein kinase inhibiting activity Woodhead, S. J.; Frederickson, M.; Hamlett, C.; Woodhead, A. J.; Verdonk, M. L.; Sore, H. F.; Walker, D. W.; Blurton, P.; Collins, I.; Cheung, K. M.; Caldwell, J.; Da Fonseca Mchardy, T. F.; Luke, R. W. A.; Matusiak, Z. S.; Leach, A.; Morris, J. J. WO/2008/075109.
22. Pyrrolo [2, 3 -d] pyrimidin derivatives as protein kinase B inhibitors. Johnson, P. D.; Leach, A; Luke, R. W. A.; Matusiak, Z. S.; Morris, J. J. WO/2009/047/563.
23. Carbamoyl compounds as DGAT1 inhibitors. Bauer, U. A.; Birch, A. M.; Butlin, R. B.; Green, C.; Barlind, J. G.; Hovland, R.; Johannesson, P.; Leach, A.; Noeske, A. T.; Petersson, A. U. WO/2009/081195
24. Substituted Pyrimidin-5-Carboxamides Gill, A. L.; Leach, A.; Packer, M.; Scott, J. S.; Sörme, P.; Swales, J. G.; Whittamore, P. R. O. WO/2009/130496.
25. Pyrazine Carboxamides As Inhibitors Of DGAT1 Birch, A. M.; Butlin, R. J.; Campbell, L.; Green, C.; Leach, A.; Murray, P. M.; Ryberg, P. O.; Waring, M. J. WO/2010/146395.
26. Adamantyl Iminocarbonyl-Substituted Pyrimidines As Inhibitors Of 11-Beta-HSD1 Bennett, S. N. L.; Goldberg, F. W.; Leach, A.; Whittamore, P. R. O.; Sörme, P. US20110092526.
27. 4-Amino-7,8-Dihydropyrimido[5,4-F][1,4]Oxazepin-5(6h)-One Based Dgat1 Inhibitors Birch, A. M.; Goldberg, F. W.; Leach, A. WO 2011121350.
29. Catalytic asymmetric cycloaddition reactions of dienes and aldehydes. Jacobsen, Eric N.; Schaus, Scott E.; Dossetter, Alexander G.; Jamison, Timothy F. (Harvard University, USA). U.S. (2001), 39 pp., US 6,130,340. 28. Asymmetric cycloaddition reactions using transition metal chiral Schiff base complexes. Jacobsen, Eric N.; Schaus, Scott E.; Dossetter, Alexander G.; Jamison, Timothy F. WO 2000050365A1
30. Preparation of cyanoguanidinoethylindoles GnRH antagonists. Wardleworth, Michael; Dossetter, Alexander Graham; Halsall, Chris T. (Astrazeneca AB, Swed.; Astrazeneca UK Limited). PCT Int.Appl. (2002), 65 pp. WO2002066459
31. Preparation of substituted imidazopyridines for antagonizing gonadotropin releasing hormone activity. Dossetter, Alexander Graham; Kenny, Peter; McKerrecher, Darren; Wardleworth, Michael. (Astrazeneca AB, Swed.; Astrazeneca UK Limited). PCT Int. Appl. (2002), 98 pp. WO2002066477A2
